Is this why the Novacyt share price keeps falling?

Rupert Hargreaves explains why the Novacyt share price is sliding and could remain under pressure as the company’s profits fall.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Novacyt (LSE: NCYT) share price has slumped over the past few weeks. The stock jumped more than 40% in the second week of August to a high of more than 420p. However, it’s since lost more than 23%, and is now trading close to its 52-week low of 290p. Over the past 12 months, the stock has lost 12% of its value.

However, since the beginning of 2020, the stock’s returned more than 2,150%, so long-term investors have been well-rewarded for holding the shares over the past two years. 

The question is, will the Novacyt share price keep falling, or can the company turn things around? 

Novacyt share price weakness 

Whenever I first come across a stock, I always try to understand the bull and bear arguments of the investment. As I’ve been covering Novacyt for the past two years, I’ve got to know the business reasonably well. 

At the beginning of 2020, shares in the company surged after Novacyt’s Primerdesign division received orders totalling €103m for its coronavirus test.

Thanks to this contract, revenue increased 900% year-on-year in the second quarter of 2020 to €36m. Then in April of this year, management announced revenues had risen further to €83m in the first quarter of 2021.

The company’s problems started earlier this year when it tried to extend a testing contract with the government. The agreement wasn’t extended even though it continued to supply testing equipment in line with demand from the Department of Health and Social Care (DHSC). 

The company is currently in a legal dispute with the Department of Health and Social Care. According to its latest trading update, it continues to work with its legal advisors. The parties still haven’t reached an agreement to extend the contract. 

Based on all of the above, it’s clear to me why the Novacyt share price has been under pressure recently. When any company loses its largest contract, the market can be spooked. 

What’s more, in theory, if an organisation’s sales and profits suddenly slump, the company will be worth less than it was. 

Slumping profits

Analysts are expecting a rapid drop-off in profitability over the next two years. The company earned £132m in 2020, but this is expected to fall to £60m in 2021, and £15m in 2022. This goes some way to explaining why the Novacyt share price has performed so poorly over the past few months. 

Of course, these are just projections at this stage. There’s no guarantee the company will hit these targets. It could earn significantly more, or significantly less. 

In the best-case scenario, the group will sort out its dispute with the DHSC, leading to a jump in sales and profitability. This could provide funding to support the firm’s expansion into other areas, establishing a more sustainable revenue stream. 

Still, despite this opportunity, I wouldn’t buy the stock for my portfolio today. As the organisation’s profits continue to slide, I think the Novacyt share price will follow suit.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »